Clinical characteristics of different histologic types of breast cancer

被引:377
作者
Li, CI [1 ]
Uribe, DJ [1 ]
Daling, JR [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
关键词
breast carcinoma; histology; SEER; stage; oestrogen receptor;
D O I
10.1038/sj.bjc.6602787
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is a heterogeneous disease, though little is known about some of its rarer forms, including certain histologic types. Using Surveillance, Epidemiology, and End Results Program data on 135 157 invasive breast cancer cases diagnosed from 1992 to 2001, relationships between nine histologic types of breast cancer and various tumour characteristics were assessed. Among women aged 50 - 89 years at diagnosis, lobular and ductal/lobular carcinoma cases were more likely to be diagnosed with stage III/ IV, >= 5.0 cm, and node-positive tumours compared to ductal carcinoma cases. Mucinous, comedo, tubular, and medullary carcinomas were less likely to present at an advanced stage. Lobular, ductal/ lobular, mucinous, tubular, and papillary carcinomas were less likely, and comedo, medullary, and inflammatory carcinomas were more likely to be oestrogen receptor ( ER) negative/ progesterone receptor ( PR) negative and high grade ( notably, 68.2% of medullary carcinomas were ER - PR - vs 19.3% of ductal carcinomas). In general, similar differences were observed among women diagnosed at age 30 - 49 years. Inflammatory carcinomas are associated with more aggressive tumour phenotypes, and mucinous, tubular, and papillary tumours are associated with less aggressive phenotypes. The histologic types of breast cancer studied here differ greatly in their clinical presentations, and the differences in their hormone receptor profiles and grades point to their likely different aetiologies.
引用
收藏
页码:1046 / 1052
页数:7
相关论文
共 28 条
[1]  
Anderson WF, 2004, CANCER EPIDEM BIOMAR, V13, P1128
[2]   Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: Distinct clinicopathologic entities? [J].
Anderson, WF ;
Chu, KC ;
Chang, S .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2254-2259
[3]   Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome [J].
Arpino, G ;
Bardou, VJ ;
Clark, GM ;
Elledge, RM .
BREAST CANCER RESEARCH, 2004, 6 (03) :R149-R156
[4]   CALCULATION OF POLYCHOTOMOUS LOGISTIC-REGRESSION PARAMETERS USING INDIVIDUALIZED REGRESSIONS [J].
BEGG, CB ;
GRAY, R .
BIOMETRIKA, 1984, 71 (01) :11-18
[5]  
Bernstein L, 1998, LOWAC J, V1S, P7
[6]   Hormone replacement therapy in relation to breast cancer [J].
Chen, CL ;
Weiss, NS ;
Newcomb, P ;
Barlow, WN ;
White, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (06) :734-741
[7]  
Daling JR, 2003, CANCER EPIDEM BIOMAR, V12, P1175
[8]  
DAVIS RP, 1979, ARCH SURG-CHICAGO, V114, P485
[9]   Hormone receptor status of breast cancer in India: a study of 798 tumours [J].
Desai, SB ;
Moonim, MT ;
Gill, AK ;
Punia, RS ;
Naresh, KN ;
Chinoy, RF .
BREAST, 2000, 9 (05) :267-270
[10]   INFILTRATING LOBULAR CARCINOMA OF THE BREAST [J].
DIXON, JM ;
ANDERSON, TJ ;
PAGE, DL ;
LEE, D ;
DUFFY, SW .
HISTOPATHOLOGY, 1982, 6 (02) :149-161